2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
2
Phase 1
2
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Breast Neoplasms
3863
Neoplasms
2989
Prostatic Neoplasms
1754
Colorectal Neoplasms
1430
Lung Neoplasms
1332
Motor Activity
805
Head and Neck Neoplasms
686
Pancreatic Neoplasms
664
Colonic Neoplasms
655
Uterine Cervical Neoplasms
653
Carcinoma, Non-Small-Cell Lung
631
Carcinoma, Hepatocellular
631
Rectal Neoplasms
571
Stomach Neoplasms
547
Brain Neoplasms
484
Ovarian Neoplasms
441
Anxiety Disorders
420
Pain
419
Neoplasm Metastasis
385
Esophageal Neoplasms
384
Polycystic Ovary Syndrome
374
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Urinary Bladder Neoplasms
351
Fatigue
340
Multiple Myeloma
323
Melanoma
323
Lymphoma
306
Depression
306
Endometrial Neoplasms
290
Liver Neoplasms
279
Interventions
Radiotherapy, Intensity-Modulated
1
Nimorazole
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Tumor Virus Infections
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled
NCT05453006
2025-07-10
Isbaar
University of Minnesota
Phase NA
Completed
3,367 enrolled
8 charts